ketorolac has been researched along with dinoprostone in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (17.65) | 18.2507 |
2000's | 19 (55.88) | 29.6817 |
2010's | 8 (23.53) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Butelman, ER; Gatch, MB; Negus, SS; Woods, JH | 1 |
Chang, JK; Ho, ML; Wang, GJ | 1 |
Hayashi, S; McDonnell, PJ; Phillips, AF; Seitz, B; Wee, WR | 1 |
Isakson, PC; Portanova, J; Seibert, K; Shaffer, A; Zhang, Y | 1 |
Chang, JK; Chuang, LY; Ho, ML; Hsu, HK; Wang, GJ | 1 |
Fernández, AG; Godessart, N; Palacios, JM; Salcedo, C | 1 |
Rivest, S; Zhang, J | 1 |
Avis, IM; Cavanaugh, PF; Chen, Z; Hong, SH; Loukinova, E; Mulshine, JL; Ondrey, FG; Van Waes, C | 1 |
Junger, H; Sorkin, LS | 1 |
Gupta, AK; Madan, S; Maitra, A; Majumdar, DK | 1 |
Brandt, MR; Furness, MS; Mello, NK; Negus, SS; Rice, KC | 1 |
Felder, RB; Francis, J; Wei, SG; Zhang, ZH | 1 |
Debelak, JP; Jones, AE; Kline, JA; Thornton, LR; Watts, JA; Younger, JG | 1 |
Brahim, JS; Dionne, RA; Gordon, SM; Kent, A; Rowan, J | 1 |
Eisenach, JC; Ma, W | 1 |
Blais, V; Rivest, S; Turrin, NP | 1 |
Buvanendran, A; Kroin, JS; Saha, C; Tuman, KJ; Watts, DE | 1 |
Al-Ghawas, M; Alkhiary, YM; Cullinane, DM; Einhorn, TA; Fitch, JL; Gerstenfeld, LC; Krall, EA; Thiede, MA; Webb, EG | 1 |
Majumdar, DK; Malhotra, M | 1 |
Ernest, P; Gayton, J; Lehmann, R; Raizman, M; Walters, T | 1 |
Bucci, FA; Waterbury, LD | 3 |
Gayton, J | 1 |
Barañano, DE; Durairaj, C; Edelhauser, HF; Handa, JT; Kim, SJ; Kompella, UB | 1 |
Awh, CC; Busbee, BG; Cleary, TS; Daniel, P; Heier, JS; Stoller, GL; Waterbury, LD | 1 |
Barnett, JM; Kim, SJ; Penn, JS; Toma, HS | 1 |
Attar, M; Borbridge, L; Galindo, D; Hollander, DA; Nguyen, C; Patel, M; Schiffman, RM; Villanueva, L; Waterbury, LD | 1 |
Cairns, BE; Dong, XD; Svensson, P; Wong, H | 1 |
Acar, DE; Acar, M; Acar, U; Erikci, A; Ornek, F; Ozdemir, O; Tanriverdi, C | 1 |
Aranda, JV; Beharry, KD; Cai, CL; Lazzaro, D; Salomone, F; Valencia, AM; Valencia, GB | 1 |
Borish, L; Pal, K; Payne, SC; Ramsden, M; Shim, YM; Steinke, JW | 1 |
Baumann, JR; Bozynski, CC; Cook, JL; Sherman, SL; Stoker, AM | 1 |
5 trial(s) available for ketorolac and dinoprostone
Article | Year |
---|---|
Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation.
Topics: Adult; Analgesia; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Mandible; Molar, Third; Pain Measurement; Pain, Postoperative; Postoperative Care; Preoperative Care; Prospective Studies; Thromboxane B2; Tooth Extraction; Tooth, Impacted | 2003 |
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2007 |
Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Double-Blind Method; Female; Humans; Immunoenzyme Techniques; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phacoemulsification | 2008 |
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Female; Humans; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phenylacetates; Retinal Diseases; Tissue Distribution; Vitrectomy; Vitreous Body | 2009 |
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates | 2011 |
29 other study(ies) available for ketorolac and dinoprostone
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.
Topics: Analgesics, Non-Narcotic; Animals; Azocines; Bradykinin; Dinoprostone; Female; Ketorolac; Macaca mulatta; Male; Morphine; Pain; Temperature; Tolmetin | 1995 |
Antiinflammatory drug effects on bone repair and remodeling in rabbits.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Bone Matrix; Bone Regeneration; Bone Remodeling; Bone Transplantation; Dinoprostone; Ionophores; Ketorolac; Male; Methylprednisolone; Rabbits; Tolmetin; Ulna | 1995 |
Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Chemotaxis, Leukocyte; Cornea; Diclofenac; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Fluorometholone; Ketorolac; Lasers, Excimer; Leukotriene B4; Neutrophils; Ophthalmic Solutions; Photorefractive Keratectomy; Rabbits; Tolmetin | 1996 |
Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.
Topics: Animals; Cyclooxygenase Inhibitors; Dinoprostone; Hyperalgesia; Inflammation; Ketorolac; Male; Rats; Rats, Sprague-Dawley; Tolmetin | 1997 |
Characteristics of primary osteoblast culture derived from rat fetal calvaria.
Topics: Alkaline Phosphatase; Animals; Cells, Cultured; Dinoprostone; Female; Fetus; Ketorolac; Osteoblasts; Pregnancy; Rats; Rats, Sprague-Dawley; Skull; Tolmetin | 1999 |
Role of COX-2 inhibition on the formation and healing of gastric ulcers induced by indomethacin in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Indomethacin; Isoenzymes; Ketorolac; Male; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides; Time Factors; Wound Healing | 1999 |
A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression; Genes, Immediate-Early; Hypothalamo-Hypophyseal System; Immune Sera; Injections, Intraventricular; Interleukin-1; Ketorolac; Male; Medulla Oblongata; Neurons; Phenylethanolamine N-Methyltransferase; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Transcription, Genetic | 2000 |
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?
Topics: Animals; Antibodies; Arachidonic Acid; Cell Division; Clinical Trials, Phase II as Topic; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; DNA-Binding Proteins; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Isoenzymes; Ketorolac; Mice; Mice, Inbred BALB C; Models, Biological; Oropharyngeal Neoplasms; Paracrine Communication; Prostaglandin-Endoperoxide Synthases; Receptors, Interleukin-6; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate; Trans-Activators; Tumor Cells, Cultured | 2000 |
Isoprostanes induce plasma extravasation in rat skin.
Topics: Animals; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; F2-Isoprostanes; Ibuprofen; Inflammation; Injections, Subcutaneous; Isoprostanes; Ketorolac; Male; Rats | 2000 |
Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies.
Topics: Acrylamides; Acrylates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Excipients; Eye Diseases; In Vitro Techniques; Inflammation; Ketorolac; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Electron; Ophthalmic Solutions; Particle Size; Polymers; Pyrrolidinones; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2000 |
Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.
Topics: Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Capsaicin; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Freund's Adjuvant; Hyperalgesia; Ketorolac; Macaca mulatta; Male; Morphine; Pain; Pain Measurement; Piperazines; Receptors, Opioid, delta | 2001 |
Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins.
Topics: Animals; Blood Pressure; Cardiovascular System; Dinoprostone; Heart Rate; Ketorolac; Kidney; Male; Medulla Oblongata; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Tumor Necrosis Factor-alpha; Vagotomy | 2003 |
Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat.
Topics: Angiography; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Disease Models, Animal; Extravascular Lung Water; Hypotension; Isoenzymes; Ketorolac; Membrane Proteins; Microspheres; Pleural Effusion; Polystyrenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Respiratory Dead Space; Survival Rate; Thromboxane B2; Thromboxane-A Synthase | 2003 |
Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation.
Topics: Animals; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Immunohistochemistry; Ketorolac; Ligation; Macrophages; Male; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sciatic Nerve; Sciatic Neuropathy; Up-Regulation | 2003 |
Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli.
Topics: Animals; Blood-Brain Barrier; Brain; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression; In Situ Hybridization; Indomethacin; Inflammation; Intramolecular Oxidoreductases; Ketorolac; Lipopolysaccharides; Male; Mice; Nitrobenzenes; Plasmids; Prostaglandin-E Synthases; Pyrazoles; Sulfonamides | 2005 |
Upregulation of cerebrospinal fluid and peripheral prostaglandin E2 in a rat postoperative pain model.
Topics: Animals; Bupivacaine; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Isoflurane; Ketorolac; Laparotomy; Male; Motor Activity; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Thoracic Surgical Procedures; Up-Regulation | 2006 |
Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment.
Topics: Animals; Biomechanical Phenomena; Bony Callus; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Fracture Fixation, Intramedullary; Fracture Healing; Fractures, Bone; Fractures, Ununited; Isoxazoles; Ketorolac; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 2007 |
Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.
Topics: Administration, Topical; Animals; Dinoprostone; Drug Compounding; Excipients; Female; Ketorolac; Male; Oils; Ointments; Osteitis; Rabbits; Treatment Outcome; Water | 2006 |
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Ketorolac; Phenylacetates | 2008 |
Concentration and dosing of ketorolac versus bromfenac.
Topics: Absorption; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Immunoenzyme Techniques; Ketorolac; Mass Spectrometry; Ophthalmic Solutions; Phacoemulsification | 2009 |
Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac; Dinoprostone; Disease Models, Animal; Drug Evaluation, Preclinical; Injections; Ketorolac; Lipopolysaccharides; Male; Rabbits; Treatment Outcome; Uveitis; Vitreous Body | 2009 |
Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Choroidal Neovascularization; Dinoprostone; Disease Models, Animal; Fluorescein Angiography; Ketorolac; Male; Rats; Rats, Inbred BN; Retina; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Dextrans; Dinoprostone; Endophthalmitis; Eye; Female; Fluorescein-5-isothiocyanate; Ketorolac; Lipopolysaccharides; Prostaglandin-Endoperoxide Synthases; Rabbits | 2011 |
Intramuscular ketorolac inhibits activation of rat peripheral NMDA receptors.
Topics: Adenosine Triphosphate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dinoprostone; Excitatory Amino Acid Agonists; Female; Injections, Intramuscular; Ketorolac; Male; Naproxen; Nociceptors; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serotonin; Trigeminal Nerve | 2012 |
Prostaglandin E
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Ketorolac; Ophthalmic Solutions; Phenylacetates; Rabbits; Vitreous Body | 2017 |
Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development.
Topics: Astrocytes; Biomimetics; Coculture Techniques; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Dinoprost; Dinoprostone; Drug Discovery; Drug Interactions; Endothelial Cells; Humans; Ibuprofen; Ketorolac; Retina; Thromboxane B2 | 2018 |
Suppression of aspirin-mediated eosinophil activation by prostaglandin E
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Cysteine; Dinoprostone; Drug Hypersensitivity; Eosinophils; Humans; Ketorolac; Leukotriene B4; Leukotrienes; Lysine; Sodium Salicylate | 2019 |
An Injectable Containing Morphine, Ropivacaine, Epinephrine, and Ketorolac Is Not Cytotoxic to Articular Cartilage Explants From Degenerative Knees.
Topics: Anesthetics, Local; Cartilage, Articular; Dinoprostone; Epinephrine; Humans; Injections, Intra-Articular; Ketorolac; Matrix Metalloproteinase 7; Matrix Metalloproteinase 8; Morphine; Pain, Postoperative; Ropivacaine | 2022 |